Cyanobacteria—From the Oceans to the Potential Biotechnological and Biomedical Applications
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Cyanobacteria are photosynthetic prokaryotic organisms which represent a significant source of novel, bioactive, secondary metabolites, and they are also considered an abundant source of bioactive compounds/drugs, such as dolastatin, cryptophycin 1, curacin toyocamycin, phytoalexin, cyanovirin-N and phycocyanin. Some of these compounds have displayed promising results in successful Phase I, II, III and IV clinical trials. Additionally, the cyanobacterial compounds applied to medical research have demonstrated an exciting future with great potential to be developed into new medicines. Most of these compounds have exhibited strong pharmacological activities, including neurotoxicity, cytotoxicity and antiviral activity against HCMV, HSV-1, HHV-6 and HIV-1, so these metabolites could be promising candidates for COVID-19 treatment. Therefore, the effective large-scale production of natural marine products through synthesis is important for resolving the existing issues associated with chemical isolation, including small yields, and may be necessary to better investigate their biological activities. Herein, we highlight the total synthesized and stereochemical determinations of the cyanobacterial bioactive compounds. Furthermore, this review primarily focuses on the biotechnological applications of cyanobacteria, including applications as cosmetics, food supplements, and the nanobiotechnological applications of cyanobacterial bioactive compounds in potential medicinal applications for various human diseases are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kurutas, E. B. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0186-5 · Cited by 2,152
Valuable Products from Biotechnology of Microalgae
Pulz, O., & Gross, W. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1647-x · Cited by 2,132 · cited 1×
“In addition, they are used in production of bioplastics, water treatment [33], hydrogen production [142], cosmetics [40], forestry, animal feed [143], and application in nanobiotechnology [36], as illustrated in Figure 8.”
MethodGenetic Engineering of Algae for Enhanced Biofuel Production
Radakovits, R., Jinkerson, R. E., Darzins, A., & Posewitz, M. C. (2010) · Eukaryotic Cell · doi:10.1128/ec.00364-09 · Cited by 1,142
Marine cyanobacteria—a prolific source of natural products
Burja, A. M., Banaigs, B., Abou-Mansour, E., Grant Burgess, J., & Wright, P. C. (2001) · Tetrahedron · doi:10.1016/s0040-4020(01)00931-0 · Cited by 841
Cyanobacteria: a precious bio-resource in agriculture, ecosystem, and environmental sustainability
Singh, J. S., Kumar, A., Rai, A. N., & Singh, D. P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00529 · Cited by 758
Polyketide biosynthesis beyond the type I, II and III polyketide synthase paradigms
Shen, B. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00020-6 · Cited by 565
Bioactive natural products from marine cyanobacteria for drug discovery
Tan, L. T. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.01.012 · Cited by 534
Applications of cyanobacteria in biotechnology
Abed, R. M. M., Dobretsov, S., & Sudesh, K. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2008.03918.x · Cited by 528
Hayashi, T., Hayashi, K., Maeda, M., & Kojima, I. (1996) · Journal of Natural Products · doi:10.1021/np960017o · Cited by 422 · cited 4×
“The inhibition of in vitro human viruses’ replication, including HCMV, HSV-1, HHV-6 and HIV-1, was impacted by the supplement of the broad-spectrum antiviral calcium spirulan.”
BackgroundInfluentialLuesch, H., Moore, R. E., Paul, V. J., Mooberry, S. L., & Corbett, T. H. (2001) · Journal of Natural Products · doi:10.1021/np010049y · Cited by 378 · cited 1×
“Apratoxin A (22) produced by Lyngbya boulloni has been shown to be cytotoxic against adenocarcinoma cells [70].”
Background
Cited by
Carroll, A. R., Copp, B. R., Davis, R. A., Keyzers, R. A., & Prinsep, M. R. (2023) · Natural Product Reports · doi:10.1039/d2np00083k · Cited by 257
Versatile Applications of Cyanobacteria in Biotechnology
Żymańczyk-Duda, E., Samson, S. O., Brzezińska-Rodak, M., & Klimek-Ochab, M. (2022) · Microorganisms · doi:10.3390/microorganisms10122318 · Cited by 64
Synthetic biology in marine cyanobacteria: Advances and challenges
Bourgade, B., & Stensjö, K. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.994365 · Cited by 28
Saleem, A., Anwar, S., Saud, S., Kamal, T., Fahad, S., & Nawaz, T. (2025) · Journal of Umm Al-Qura University for Applied Sciences · doi:10.1007/s43994-025-00261-2 · Cited by 19
Carbon capture, storage, and utilization in cyanobacteria
Majhi, B. K. (2026) · Carbon Resources Conversion · doi:10.1016/j.crcon.2025.100388 · Cited by 2
Metadata
- Authors
- Khalifa, S. A. M., Shedid, E. S., Saied, E. M., Jassbi, A. R., Jamebozorgi, F. H., Rateb, M. E., Du, M., Abdel-Daim, M. M., Kai, G.-Y., Al-Hammady, M. A. M., Xiao, J., Guo, Z., & El-Seedi, H. R.
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2021-04-24
- Volume
- 19
- Issue
- 5
- Pages
- 241
- ISSN
- 1660-3397 (ISSN-L)
- OpenAlex
- W3158735209
- Cited by
- 128
- References
- 26
- FWCI
- 11.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cyanobacteria—From the Oceans to the Potential Biotechnological and Biomedical Applications. https://app.cochat.ai/papers/10.3390/md19050241
- The paper
- Khalifa, S. A. M., Shedid, E. S., Saied, E. M., Jassbi, A. R., Jamebozorgi, F. H., Rateb, M. E., Du, M., Abdel-Daim, M. M., Kai, G.-Y., Al-Hammady, M. A. M., Xiao, J., Guo, Z., & El-Seedi, H. R. (2021). Cyanobacteria—From the Oceans to the Potential Biotechnological and Biomedical Applications. Marine Drugs. https://doi.org/10.3390/md19050241
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.